Tumor metabolism as modulator of immune response and tumor progression - PubMed
Review
Tumor metabolism as modulator of immune response and tumor progression
Eva Gottfried et al. Semin Cancer Biol. 2012 Aug.
Abstract
About a century ago Otto Warburg observed that tumor cells exhibited increased glycolysis despite the presence of oxygen and stated this metabolic shift to glycolysis as the origin of cancer cell. In the meantime it has become clear, that the altered glucose metabolism is only one piece of the tumor metabolome puzzle. In addition, amino acid, lipid and adenosine metabolism are adapted to fulfill the tumors needs for energy and generation of building blocks such as lipids and nucleotides for new cell structures. The altered tumor metabolism leads to accumulation of specific metabolites in the tumor environment and creates a favorable milieu for tumor growth, progression and metastasis. These tumor-derived metabolites are important players in immune escape mechanisms beside other known factors such as cytokines, chemokines and growth factors. A variety of metabolites re-educate immune cells and prevent an effective immune response against tumor cells. Furthermore, tumor infiltrating immune cells support tumor growth by the secretion of cytokines, growth factors and other metabolic determinants. Hence, a complex interplay of tumor metabolites, cytokines and stromal factors is active in tumors and facilitates their establishment and growth. Pharmacological blockade of tumor metabolites could overcome some limitations of cancer treatment and rescue the endogenous immune response against tumor cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Lactate: a metabolic key player in cancer.
Hirschhaeuser F, Sattler UG, Mueller-Klieser W. Hirschhaeuser F, et al. Cancer Res. 2011 Nov 15;71(22):6921-5. doi: 10.1158/0008-5472.CAN-11-1457. Cancer Res. 2011. PMID: 22084445 Review.
-
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Helmlinger G, et al. Clin Cancer Res. 2002 Apr;8(4):1284-91. Clin Cancer Res. 2002. PMID: 11948144
-
The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA, Gawlinski ET. Gatenby RA, et al. Cancer Res. 2003 Jul 15;63(14):3847-54. Cancer Res. 2003. PMID: 12873971
-
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
Ganapathy V, Thangaraju M, Prasad PD. Ganapathy V, et al. Pharmacol Ther. 2009 Jan;121(1):29-40. doi: 10.1016/j.pharmthera.2008.09.005. Epub 2008 Nov 1. Pharmacol Ther. 2009. PMID: 18992769 Review.
-
Adaptation of energy metabolism in breast cancer brain metastases.
Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR 3rd, Felding-Habermann B. Chen EI, et al. Cancer Res. 2007 Feb 15;67(4):1472-86. doi: 10.1158/0008-5472.CAN-06-3137. Cancer Res. 2007. PMID: 17308085
Cited by
-
Association of endometriosis with Sjögren's syndrome: Genetic insights (Review).
Zervou MI, Tarlatzis BC, Grimbizis GF, Spandidos DA, Niewold TB, Goulielmos GN. Zervou MI, et al. Int J Mol Med. 2024 Feb;53(2):20. doi: 10.3892/ijmm.2024.5344. Epub 2024 Jan 8. Int J Mol Med. 2024. PMID: 38186322 Free PMC article. Review.
-
Chen H, Zu F, Zeng T, Chen Z, Wei J, Liu P, Li Z, Zhou L, Wang H, Tan H, Tan X. Chen H, et al. Front Oncol. 2022 Jan 19;11:757791. doi: 10.3389/fonc.2021.757791. eCollection 2021. Front Oncol. 2022. PMID: 35127473 Free PMC article.
-
Mast Cells as Important Regulators in Autoimmunity and Cancer Development.
Noto CN, Hoft SG, DiPaolo RJ. Noto CN, et al. Front Cell Dev Biol. 2021 Oct 12;9:752350. doi: 10.3389/fcell.2021.752350. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34712668 Free PMC article. Review.
-
Eosinophils: The unsung heroes in cancer?
Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, Marone G, Schiavoni G. Varricchi G, et al. Oncoimmunology. 2017 Nov 13;7(2):e1393134. doi: 10.1080/2162402X.2017.1393134. eCollection 2018. Oncoimmunology. 2017. PMID: 29308325 Free PMC article. Review.
-
Ge LL, Wang ZC, Wei CJ, Huang JX, Liu J, Gu YH, Wang W, Li QF. Ge LL, et al. Cancer Immunol Immunother. 2023 Dec;72(12):4415-4429. doi: 10.1007/s00262-023-03577-2. Epub 2023 Nov 8. Cancer Immunol Immunother. 2023. PMID: 37938367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources